PubRank

Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm

Clinical Trial ID NCT03508882

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03508882

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm. Arch Ophthalmol 2006 2.36
2 Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990 1.67
3 Pretarsal application of botulinum toxin for treatment of blepharospasm. J Neurol Neurosurg Psychiatry 1995 1.47
4 Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. J Neurol Neurosurg Psychiatry 1996 1.41
5 Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 2009 1.36
6 Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 2004 1.22
7 Dystonia rating scales: critique and recommendations. Mov Disord 2013 1.17
8 Botulinum toxin in ophthalmology. Surv Ophthalmol 2007 1.10
9 Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome. Am J Ophthalmol 2013 1.04
10 Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neurol 2002 1.02
11 Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia. J Neurol Neurosurg Psychiatry 2001 1.01
12 Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm. J Neural Transm (Vienna) 2011 0.91
13 Blepharospasm with basal ganglia lesions. Arch Neurol 1986 0.85
14 Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev 2005 0.85
15 Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment. J Neural Transm (Vienna) 2012 0.83
16 Pharmacology of botulinum toxin. J Am Acad Dermatol 2000 0.82
17 Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening. J Neurol Neurosurg Psychiatry 1996 0.82
18 Botulinum toxin for the treatment of movement disorders. Curr Neurol Neurosci Rep 2012 0.81
19 Evaluating effects of preservative-containing saline solution on pain perception during botulinum toxin type-a injections at different locations: a prospective, single-blinded, randomized controlled trial. Aesthetic Plast Surg 2005 0.81
20 Chemodenervation for facial dystonias and wrinkles. Curr Opin Ophthalmol 2003 0.79
21 Proximal tarsal attachments of the levator aponeurosis: implications for blepharoptosis repair. Ophthalmology 2013 0.77
22 Pain relief in patients receiving periocular botulinum toxin A. Ophthal Plast Reconstr Surg 2008 0.75
23 Eyelid eversion for visualisation of the upper eyelid lamellae: an anatomical cadaver study. Br J Ophthalmol 2011 0.75
Next 100